Login / Signup
Yoshifumi Kawamura
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Signaling Pathway
Cancer Therapy
Cell Death
Drug Delivery
Top Venues
Cancer science
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yoshifumi Kawamura
,
Ken Saijo
,
Hiroo Imai
,
Chikashi Ishioka
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells.
Cancer science
112 (11) (2021)